Cost-Effectiveness Analysis of Pneumococcal Vaccination for Elderly Individuals in The Netherlands

@article{Postma2001CostEffectivenessAO,
  title={Cost-Effectiveness Analysis of Pneumococcal Vaccination for Elderly Individuals in The Netherlands},
  author={Dr Maarten J. Postma and M. L. Heijnen and Johannes C. Jager},
  journal={PharmacoEconomics},
  year={2001},
  volume={19},
  pages={215-222}
}
Objective: To assess the cost effectiveness (net costs per life year gained) of pneumococcal vaccination of elderly individuals aged 65 years and over in The Netherlands. Design and setting: A pharmacoeconomic analysis was conducted from the healthcare perspective in The Netherlands. The gender- and age-specific modelling framework linked epidemiological aspects of invasive pneumococcal disease (e.g. incidence, mortality, life years lost) to vaccination and hospital resource use. To derive 90… CONTINUE READING